Skip to content
  • (+359) 2 9156 100
  • Bulgarian
  • English
  • Macedonian
BorolaBorola
  • Home
  • About us
    • Certificates
  • Products
    • Nutraceuticals
      • Products A-Z
      • Antioxidants & Vitamins
      • Gastroenterology
      • Dermatology
      • Child Health
      • Endocrinology
      • Women’s Health
      • Immunology
      • Cardiovascular
      • Men’s Health
      • Neurology
      • Oncology
      • Bone Health
      • Urology
      • Weight management
      • Eye Health
      • Dental Health
      • Urology
      • Ear, Nose & Throat
    • Cosmetic line
      • GinGira® Activ Spray 30 ml
      • GinGira® Alba Bebe Spray 100 ml
      • GinGira® Alba Bebe Spray 30 ml
      • GinGira® Alba Spray 100 ml
      • GinGira® Alba Spray 50 ml
      • GinGira® Medicasol Spray 30 ml
      • Lipobase® cream 100ml
      • Nanobase® cream 30ml
    • Pharmaceuticals
      • Lamisil® 1% Cream (15 g & 30 g)
      • Lamisil® Cutaneous spray 1%
      • Doloproct® 1 mg/40 mg, suppositories
      • Doloproct® 1 mg/g +20 mg/g, rectal cream
      • GYNO-PEVARYL® 50 mg pessaries
      • GYNO-PEVARYL® 150 mg pessaries
      • Medicinal safety
    • Medical devices
      • Lactobor® Intim
  • Services
    • Regulatory
    • Marketing
    • Distribution
    • Clinical
      • Borola Clinic
      • Health Programs
      • Occupational Health
      • Clinical Trials
    • Packaging
  • News
  • Contacts
Regulatory

Borola’s strong regulatory and scientific team consists of physicians, chemists, biologists, pharmacists and external consultants. We assist our clients with a wide range of regulatory affairs services such as:

  • registration of pharmaceutical products, medical devices, natural health products and cosmetics,
  • securing authorizations to conduct clinical trials,
  • import of investigational drugs,
  • provision of regulatory affairs education and training
  • performance of clinical trials in collaboration with leading institutions and medical specialists; and
  • pharmacovigilance services
Borola LTD

Address:z.k. Ovcha Kupel 2, Block 2A, Ground Floor, Sofia 1632
Tel.: (+359) 2 9156 100
Fax: (+359) 2 9156 111
E-mail: office@borola.com

Products
  • Nutraceuticals
  • Cosmetic line GinGira
  • Pharmaceuticals
  • Medical devices
  • Other products
Services
  • Regulatory
  • Marketing
  • Distribution
  • Clinical
  • Packaging
Important Links
  • Online shop
  • Borola Clinic
  • Cosmetics GinGira
  • Clinical trial
  • Care for psoriatic patients
Copyright © 2025 Borola | All rights reserved.
Web design and SEO by Tribest
  • Products
  • Home
  • About us
    • Certificates
  • Products
    • Nutraceuticals
      • Products A-Z
      • Antioxidants & Vitamins
      • Gastroenterology
      • Dermatology
      • Child Health
      • Endocrinology
      • Women’s Health
      • Immunology
      • Cardiovascular
      • Men’s Health
      • Neurology
      • Oncology
      • Bone Health
      • Urology
      • Weight management
      • Eye Health
      • Dental Health
      • Urology
      • Ear, Nose & Throat
    • Cosmetic line
      • GinGira® Activ Spray 30 ml
      • GinGira® Alba Bebe Spray 100 ml
      • GinGira® Alba Bebe Spray 30 ml
      • GinGira® Alba Spray 100 ml
      • GinGira® Alba Spray 50 ml
      • GinGira® Medicasol Spray 30 ml
      • Lipobase® cream 100ml
      • Nanobase® cream 30ml
    • Pharmaceuticals
      • Lamisil® 1% Cream (15 g & 30 g)
      • Lamisil® Cutaneous spray 1%
      • Doloproct® 1 mg/40 mg, suppositories
      • Doloproct® 1 mg/g +20 mg/g, rectal cream
      • GYNO-PEVARYL® 50 mg pessaries
      • GYNO-PEVARYL® 150 mg pessaries
      • Medicinal safety
    • Medical devices
      • Lactobor® Intim
  • Services
    • Regulatory
    • Marketing
    • Distribution
    • Clinical
      • Borola Clinic
      • Health Programs
      • Occupational Health
      • Clinical Trials
    • Packaging
  • News
  • Contacts
  • Bulgarian
  • English
  • Macedonian